Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.2.234

Prevalence of HPV Infection and HPV Genotype Spectrum among Sexually High-Risk Women in Busan  

Min, Sang-Kee (Division of Epidemiology, Busan Institute of Health and Environment)
Kim, Sung-Soon (Divison of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Center for Disease Control & Prevention)
Choi, Byeong-Sun (Divison of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Center for Disease Control & Prevention)
Cho, Kyung-Soon (Division of Epidemiology, Busan Institute of Health and Environment)
Lee, Joo-Yun (Division of Epidemiology, Busan Institute of Health and Environment)
Kim, Seong-Joon (Division of Epidemiology, Busan Institute of Health and Environment)
Bin, Jae-Hun (Division of Epidemiology, Busan Institute of Health and Environment)
Park, Ho-Kuk (Division of Epidemiology, Busan Institute of Health and Environment)
Publication Information
Journal of Life Science / v.19, no.2, 2009 , pp. 234-240 More about this Journal
Abstract
We tried to analyze the HPV prevalence and HPV genotypes of sexually high-risk women living in Busan, the biggest seaport of South Korea. Six hundred sixty women engaging in high-risk occupations participated in this study. The prevalence of HPV infection and HPV genotyping were determined with $MyGene^{(R)}$ HPVDNA chip, which consisted of 16 high-risk HPV genotypes (oncogenic genotypes) and 8 low-risk HPV genotypes. The overall prevalence of HPV infection in this study population was 39.1% (258/660) and the 20's showed the highest prevalence of HPV infection (51.5%). The dominant HPV genotypes including single or multiple HPV-infected women were resulted in HPV-16 (15.9%), -53 (10.2%), -58 (7.7%), -18 (5.2%) in case of high-risk HPV genotype and HPV-70 (10.4%), -6 (4.1%), -11 (2.0%) in case of low-risk HPV genotypes. Remarkably, the proportion of women infected with high-risk HPV genotypes (62.0%) was almost four times higher than those of women infected with low-risk HPV genotypes (14.7%) and high/low-risk HPV genotypes (12.0%). Among the 258 HPV-infected women, single infection was 175, double infection 66, triple infection 12, quadruple infection 4, quintuple infection 1, respectively. Our finding suggests that the introduction and development of effective HPV vaccines should consider the current status of HPV genotypic infection in South Korean women.
Keywords
HPV genotype; HPVDNA chip; sexually high-risk women;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Matos, E., D. Loria, G. M. Amestoy, L. Herrera, M. A. Prince, J. Moreno, C. Krunfly, A. J. C. Van Den Brule, C. J. L. M. Meijer, N. Munoz, R. Herrero, and Proyecto Concordia Collaborative Group. 2003. Prevalence oh human papillomavirus infection among in Concordia, Argentina. Sex Transm. Dis. 30, 593-599   DOI   ScienceOn
2 Molano, M., H. Posso, E. Weiderpass, M. Ronderos, S. Franceschi, C. J. Meijer, A. Arslan, and N. Munoz. 2002. Prevalence and determinants of HPV infection among Columbian women with normal cytology. Br. J. Cancer 87, 324-333   DOI   ScienceOn
3 Munoz, N. 2003. International Agency for research on cancer multicenter cervical cancer study group. Epidemiologic classfication of human papillomavirus types associated with cervical cancer. N. Eng. J. Med. 348, 518-527   DOI   ScienceOn
4 Park, C. S., Y. D. Choi, W. W. Jung, J. H. Nam, and H. S. Choi. 2005. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Gynecol. Oncol. 90, 51-56   DOI   ScienceOn
5 Shin, H. R., D. H. Lee, R. Herrero, J. S. Smith, S. Vaccarella, S. H. Hong, K. Y. Jung, H. H. Kim, U. D. Park, H. S. Cha, S. Y. Park, A. Touze, N. Munoz, P. J. Snijders, C. J., Meijer, P. Coursaget, and S. Franceschi. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer 103, 413-421   DOI   ScienceOn
6 Shin, H. R., S. Franceschi, S. Vaccarella, J. W. Roh, Y. H. Ju, J. K. Oh, H. J. Kong, S. H. Rha, S. I. Jung, J. I. Kim, K. Y. Jung, L. J. van Doorn, and W. Quint. 2004. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J. Infect. Dis. 190, 468-476   DOI   ScienceOn
7 Touze, A., S. Sanjose, P. Coursage, M. R. Almirall, V. Palacio, C. J. Meijer, J. Kornegay, and F. X. Bosch. 2001. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particle in women in the general population and in prostitutes. J. Clin. Microbiol. 39, 4344-4348   DOI   ScienceOn
8 Jung, W. W., T. Chun, D. Sul, K. W. Hwang, H. S. Kang, D. J. Lee, and I. K. Han. 2004. Strategies against human papillomavirus infection and cervical cancer. J. Microbiol. 42, 255-266
9 Kahng, J. M. and H. J. Lee. 2008. Clinical efficacy of HPVDNA chip test in the era of HPV vaccination. Korean J. Lab. Med. 28, 70-78   DOI   ScienceOn
10 Kim, K. H., M. S. Yoon, Y. J. Na, C. S. Park, M. R. Oh, and W. C. Moon. 2006. Development evaluation of a highly sensitive human papillomavirus genotyping DNA chip. Gynecol. Oncol. 100, 38-43   DOI   ScienceOn
11 Kim, Y. T. 2007. Natural history of HPV and carcinogenesis of cervical cancer, Korean J. Obstet. Gynecol. 50, 711-720
12 Koutsky, L. 1997. Epidermiology of genital human papillomavirus infection. Am. J. Med. 102, 3-8
13 Lehtinen, M., J. Diller, P. Knekt, T. Luostarinen, A. Aromaa, R. Kirnbauer, P. Koskela, J. Paavonen, R. Peto, J. T. Schiller, and M. Hakama. 1996. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma. BMJ. 312, 537-539   DOI
14 Levi, J. E., B. Kleter, G. V. Wim, C. S. Maria, L. M. Cynthia, M. Regina, L. Iara, and L. J. Doorn. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus infected women in Brazil. J. Clin. Microbiol. 40, 3341-3345   DOI   ScienceOn
15 Luis, A. J. F., C. M. Wheeler, J. U. S. Felipe, J. C. G. Carlos, G. Z. M. Laura, G. C. Santa, and H. A. Mauricio. 2001. Human papillomavirus: A highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm. Dis. 28, 125-130   DOI   ScienceOn
16 Eduardo, L. P., H. Rolando, M. Nubia, C. Aurelio, V. S. Keerti, A. Patricia, H. Pilar, S. Jorge, and H. Mauricio. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91, 412-420   DOI   ScienceOn
17 Eileen, F. D. and L. E. Markowitz. 2006. Genital human papillomavirus infection. Clin. Infect. Dis. 43, 624-629   DOI   ScienceOn
18 Eileen, M. Burd. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16, 1-17   DOI   ScienceOn
19 Eileen, F. D., L. K. Kelvin, R. S. Maya, M. S. Ketherine, R. U. Elizabeth, C. R. William, and L. E. Markowitz. 2005. Serovalence of human papillomavirus type 16 in children. J. Infect. Dis. 191, 1817-1819
20 Eileen, F. D., M. N. Carrie, M. S. Katherine, E. M. Laurie, and R. G. Anna. 2006. Prevalence of HPV infection among man: a systematic review of the literature. J. Infect. Dis. 194, 1044-1057   DOI   ScienceOn
21 Figueroa, J. P., E. Ward, T. E. Luthi, S. H. Vermund, A. R, Brathwaite, and R. D. Burk. 1995. Prevalence of human papillomavirus among STD clinic attenders in Jamaica. Sex Transm. Dis. 22, 114-118   DOI   ScienceOn
22 Franco, E. L. and D. M. Harper. 2005. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23, 2388-2394   DOI   ScienceOn
23 Hwang, T. S., J. K. Jeong, M. Park, H. S. Han, H. K. Choi, and T. S. Park. 2003. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol. Oncol. 90, 51-56   DOI   ScienceOn
24 Ishi, K., F. Suzuki, A. Saito, and T. Kubota. 2000. Prevalence of human papillomavirus, Chlamydia trachomatis and Neissera gonorrhoeae in commercial sex workers in Japan. Infect. Dis. Obstet. Gynecol. 8, 235-239
25 An, H. J., N. H. Cho, S. Y. Lee, I. H. Kim, and S. J. Kim. 2003.Correlation of cervical carcinoma and precancerous legions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97, 1672-1680   DOI   ScienceOn
26 Chan, P. K., K. H. Mark, J. L. Cheung, N. L. Tang, D. P. Chan, K. K. Lo, and A. F. Cheng. 2002. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J. Med. Virol. 68, 273-277   DOI   ScienceOn
27 Bosch, F. X., M. M. Manos, N. Munos, M. Sherman, A. M. Jansen, and J. Peto. 1995. Prevalence of HPV in cervical cancer. J. Natl. Cancer Inst. 87, 796-802   DOI   ScienceOn
28 Castellsague, X., C. Menendez, M. P. Loscertales, J. R. Kornegay, F. Santos, A. Barreto, F. X. Bosch, and P. Alonso. 2001. Human papillomavirus genotypes in rural Mozambique. Lancet 358, 1429-1430   DOI   ScienceOn
29 Cates, W. Jr. 1999. Estimates of the incidence and prevalence of sexually transmitted disease in the United States: American social health association panel. Sex Transm. Dis. 26, 2-7   DOI   ScienceOn
30 Chen, S., H. O. Sullivan, S. N. Tabrizi, C. K.Fairley, M. A. Quinn, and S. M. Garland. 1999. Prevalence and genotyping of HPV in cervical cancer among Australian women. Int. J. Gynecol. Obstet. 67, 163-168   DOI   ScienceOn
31 Choi, B. S., O. J. Kim, M. S. Park, K. S. Kim, J. M. Kim, and J. S. Lee. 2003. Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J. Med. Virol. 71, 440-445   DOI   ScienceOn
32 Editorial. 1997. Do HPV-negative cervical carcinomas exit?. J. pathol. 181, 253-254   DOI   ScienceOn
33 Agosti, J. M. and S. J. Goldie. 2007. Introducing HPV vaccine in developing countries. N. Eng. J. Med. 356, 1908-1910   DOI   ScienceOn